Common use of WORK STATEMENT Clause in Contracts

WORK STATEMENT. This Work Statement NB-1 is entered into pursuant to Section 2.1 of the Clinical Trial Services Agreement dated as of March 29, 2011, by and between Radius Health, Inc. (“Radius”) and Nordic Bioscience Clinical Development VII A/S (“NB”) (the “Agreement”). Capitalized terms used in this Work Statement NB-1 and not defined in this Work Statement NB-1 are used with the meanings ascribed to them in the Agreement. This Work Statement NB-1 is attached to and becomes, upon execution by both parties below but subject to the consummation by Radius of an equity financing pursuant to which it shall have issued and sold shares of its Series A-1 Convertible Preferred Stock, par value $0.01 per share, to existing and/or new investors resulting in aggregate gross proceeds being received by Radius in an amount equal to approximately [*] U.S. Dollars (US$[*]) (unless waived by Radius), a part of the Agreement, and sets forth the specific terms and conditions relating to the Services and Deliverables described herein. In consideration of the mutual promises contained in the Agreement and for other good and valuable consideration the receipt and adequacy of which each of the parties does hereby acknowledge, the parties hereby agree to the terms of this Work Statement NB-1 entitled “A Randomized, Double-blind, Placebo-controlled, Comparative Phase 3 Multicenter Study to Evaluate the Safety and Efficacy of BA058 for Injection for Prevention of Fracture in Ambulatory Postmenopausal Women with Severe Osteoporosis and at Risk of Fracture”. This Work Statement NB-1 contains the following Attachments, each of which is made a part hereof: Attachment A — Specifications/Key Assumptions/Services/Division of Responsibilities/Timeline Specifications Attachment B — Budgets, Fees, Pass-through Costs, and Payment Schedule Attachment C — Materials Provided by Either Party Attachment D — Core Team Members/Key Personnel Attachment E — Protocol or Protocol Summary Attachment F — Reports and Information Management/Regular Meetings Attachment G — Special Insurance Attachment H - Transfer of Obligation

WORK STATEMENT. This Work Statement NB-1 is entered into pursuant to Section 2.1 of the Clinical Trial Services Agreement dated as of March 29, 2011, by and between Radius Health, Inc. (“Radius”) and Nordic Bioscience Clinical Development VII A/S (“NB”) (the “Agreement”). Capitalized terms used in this Work Statement NB-1 and not defined in this Work Statement NB-1 are used with the meanings ascribed to them in the Agreement. This Work Statement NB-1 is attached to and becomes, upon execution by both parties below but subject to the consummation by Radius of an equity financing pursuant to which it shall have issued and sold shares of its Series A-1 Convertible Preferred Stock, par value $0.01 per share, to existing and/or new investors resulting in aggregate gross proceeds being received by Radius in an amount equal to approximately [*] sixty million U.S. Dollars (US$[*]60,000,000) (unless waived by Radius), a part of the Agreement, and sets forth the specific terms and conditions relating to the Services and Deliverables described herein. In consideration of the mutual promises contained in the Agreement and for other good and valuable consideration the receipt and adequacy of which each of the parties does hereby acknowledge, the parties hereby agree to the terms of this Work Statement NB-1 entitled “A Randomized, Double-blind, Placebo-controlled, Comparative Phase 3 Multicenter Study to Evaluate the Safety and Efficacy of BA058 for Injection for Prevention of Fracture in Ambulatory Postmenopausal Women with Severe Osteoporosis and at Risk of Fracture”. This Work Statement NB-1 contains the following Attachments, each of which is made a part hereof: Attachment A — Specifications/Key Assumptions/Services/Division of Responsibilities/Timeline Specifications Attachment B — Budgets, Fees, Pass-through Costs, and Payment Schedule Attachment C — Materials Provided by Either Party Attachment D — Core Team Members/Key Personnel Attachment E — Protocol or Protocol Summary Attachment F — Reports and Information Management/Regular Meetings Attachment G — Special Insurance Attachment H - Transfer of Obligation